Annual FCF
-$64.35 M
-$20.80 M-47.77%
31 December 2023
Summary:
Lyra Therapeutics annual free cash flow is currently -$64.35 million, with the most recent change of -$20.80 million (-47.77%) on 31 December 2023. During the last 3 years, it has fallen by -$41.43 million (-180.79%). LYRA annual FCF is now -863.77% below its all-time high of -$6.68 million, reached on 31 December 2018.LYRA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$16.27 M
+$3.90 M+19.34%
30 September 2024
Summary:
Lyra Therapeutics quarterly free cash flow is currently -$16.27 million, with the most recent change of +$3.90 million (+19.34%) on 30 September 2024. Over the past year, it has dropped by -$2.02 million (-14.14%). LYRA quarterly FCF is now -690.49% below its all-time high of $2.76 million, reached on 30 June 2021.LYRA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$80.90 M
-$2.02 M-2.56%
30 September 2024
Summary:
Lyra Therapeutics TTM free cash flow is currently -$80.90 million, with the most recent change of -$2.02 million (-2.56%) on 30 September 2024. Over the past year, it has dropped by -$24.20 million (-42.69%). LYRA TTM FCF is now -2546.39% below its all-time high of -$3.06 million, reached on 31 March 2019.LYRA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.8% | -14.1% | -42.7% |
| 3 y3 years | -180.8% | -50.3% | -240.0% |
| 5 y5 years | -863.8% | -324.1% | -711.7% |
LYRA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -180.8% | at low | -91.8% | +33.9% | -240.0% | at low |
| 5 y | 5 years | -863.8% | at low | -690.5% | +33.9% | -711.7% | at low |
| alltime | all time | -863.8% | at low | -690.5% | +33.9% | -2546.4% | at low |
Lyra Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.27 M(-19.3%) | -$80.90 M(+2.6%) |
| June 2024 | - | -$20.18 M(-18.0%) | -$78.88 M(+8.0%) |
| Mar 2024 | - | -$24.60 M(+24.0%) | -$73.06 M(+13.5%) |
| Dec 2023 | -$64.35 M(+47.8%) | -$19.84 M(+39.2%) | -$64.35 M(+13.5%) |
| Sept 2023 | - | -$14.26 M(-0.7%) | -$56.70 M(+6.3%) |
| June 2023 | - | -$14.35 M(-9.7%) | -$53.31 M(+12.4%) |
| Mar 2023 | - | -$15.89 M(+30.4%) | -$47.45 M(+8.9%) |
| Dec 2022 | -$43.55 M(+49.1%) | -$12.19 M(+12.1%) | -$43.55 M(-0.4%) |
| Sept 2022 | - | -$10.88 M(+28.2%) | -$43.74 M(+0.1%) |
| June 2022 | - | -$8.48 M(-29.3%) | -$43.69 M(+34.6%) |
| Mar 2022 | - | -$12.00 M(-3.1%) | -$32.45 M(+11.1%) |
| Dec 2021 | -$29.20 M | -$12.38 M(+14.3%) | -$29.20 M(+22.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$10.83 M(-493.0%) | -$23.79 M(+37.3%) |
| June 2021 | - | $2.76 M(-131.5%) | -$17.33 M(-37.3%) |
| Mar 2021 | - | -$8.75 M(+25.6%) | -$27.64 M(+20.6%) |
| Dec 2020 | -$22.92 M(+64.1%) | -$6.97 M(+59.5%) | -$22.92 M(+14.9%) |
| Sept 2020 | - | -$4.37 M(-42.2%) | -$19.95 M(+2.7%) |
| June 2020 | - | -$7.55 M(+87.7%) | -$19.41 M(+30.0%) |
| Mar 2020 | - | -$4.03 M(+0.7%) | -$14.93 M(+6.9%) |
| Dec 2019 | -$13.96 M(+109.2%) | -$4.00 M(+4.2%) | -$13.96 M(+40.1%) |
| Sept 2019 | - | -$3.84 M(+24.9%) | -$9.97 M(+62.6%) |
| June 2019 | - | -$3.07 M(+0.5%) | -$6.13 M(+100.5%) |
| Mar 2019 | - | -$3.06 M | -$3.06 M |
| Dec 2018 | -$6.68 M | - | - |
FAQ
- What is Lyra Therapeutics annual free cash flow?
- What is the all time high annual FCF for Lyra Therapeutics?
- What is Lyra Therapeutics annual FCF year-on-year change?
- What is Lyra Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly FCF year-on-year change?
- What is Lyra Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Lyra Therapeutics?
- What is Lyra Therapeutics TTM FCF year-on-year change?
What is Lyra Therapeutics annual free cash flow?
The current annual FCF of LYRA is -$64.35 M
What is the all time high annual FCF for Lyra Therapeutics?
Lyra Therapeutics all-time high annual free cash flow is -$6.68 M
What is Lyra Therapeutics annual FCF year-on-year change?
Over the past year, LYRA annual free cash flow has changed by -$20.80 M (-47.77%)
What is Lyra Therapeutics quarterly free cash flow?
The current quarterly FCF of LYRA is -$16.27 M
What is the all time high quarterly FCF for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly free cash flow is $2.76 M
What is Lyra Therapeutics quarterly FCF year-on-year change?
Over the past year, LYRA quarterly free cash flow has changed by -$2.02 M (-14.14%)
What is Lyra Therapeutics TTM free cash flow?
The current TTM FCF of LYRA is -$80.90 M
What is the all time high TTM FCF for Lyra Therapeutics?
Lyra Therapeutics all-time high TTM free cash flow is -$3.06 M
What is Lyra Therapeutics TTM FCF year-on-year change?
Over the past year, LYRA TTM free cash flow has changed by -$24.20 M (-42.69%)